Cargando…
Overview of Blood Transfusion System of Iran: 2002–2011
Despite importance of blood transfusion services as life saving procedures, some countries are unable to meet their national requirements for blood and blood components in a timely manner. Since establishment of Iran Blood Transfusion Organization (IBTO) in 1974 as an integral part of national healt...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469026/ https://www.ncbi.nlm.nih.gov/pubmed/23113231 |
_version_ | 1782246026541793280 |
---|---|
author | Cheraghali, AM |
author_facet | Cheraghali, AM |
author_sort | Cheraghali, AM |
collection | PubMed |
description | Despite importance of blood transfusion services as life saving procedures, some countries are unable to meet their national requirements for blood and blood components in a timely manner. Since establishment of Iran Blood Transfusion Organization (IBTO) in 1974 as an integral part of national health system, Iran has experienced a drastic improvement both in availability and safety of blood and blood products. Iran now has not only reached to a 100% non remunerated voluntary blood donation but also secured a national self sufficiency of blood and blood components. Efforts of IBTO as the sole player of transfusion medicines in Iran enabled the country for timely providing of life saving blood transfusion services for all Iranian patients in need of such services. In order to meet the country’s demand in 2011 about 2 million units of whole blood for a population of about 75 million collected by IBTO. This indicates 26.2 donations per 1000 population. Currently about 94% of blood donors in Iran are 25–35 years old males and contribution of female donors in blood donation is less than 6%. IBTO screen all donated blood for important transfusion transmissible infections such as HBV, HIV, HCV and syphilis. Prevalence of HBsAg, HCV and HIV in donated blood in IBTO in 2011 was 0.20%, 0.06% and 0.004% respectively. |
format | Online Article Text |
id | pubmed-3469026 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Tehran University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-34690262012-10-30 Overview of Blood Transfusion System of Iran: 2002–2011 Cheraghali, AM Iran J Public Health Report Article Despite importance of blood transfusion services as life saving procedures, some countries are unable to meet their national requirements for blood and blood components in a timely manner. Since establishment of Iran Blood Transfusion Organization (IBTO) in 1974 as an integral part of national health system, Iran has experienced a drastic improvement both in availability and safety of blood and blood products. Iran now has not only reached to a 100% non remunerated voluntary blood donation but also secured a national self sufficiency of blood and blood components. Efforts of IBTO as the sole player of transfusion medicines in Iran enabled the country for timely providing of life saving blood transfusion services for all Iranian patients in need of such services. In order to meet the country’s demand in 2011 about 2 million units of whole blood for a population of about 75 million collected by IBTO. This indicates 26.2 donations per 1000 population. Currently about 94% of blood donors in Iran are 25–35 years old males and contribution of female donors in blood donation is less than 6%. IBTO screen all donated blood for important transfusion transmissible infections such as HBV, HIV, HCV and syphilis. Prevalence of HBsAg, HCV and HIV in donated blood in IBTO in 2011 was 0.20%, 0.06% and 0.004% respectively. Tehran University of Medical Sciences 2012-08-31 /pmc/articles/PMC3469026/ /pubmed/23113231 Text en Copyright © Iranian Public Health Association & Tehran University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0), which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly. |
spellingShingle | Report Article Cheraghali, AM Overview of Blood Transfusion System of Iran: 2002–2011 |
title | Overview of Blood Transfusion System of Iran: 2002–2011 |
title_full | Overview of Blood Transfusion System of Iran: 2002–2011 |
title_fullStr | Overview of Blood Transfusion System of Iran: 2002–2011 |
title_full_unstemmed | Overview of Blood Transfusion System of Iran: 2002–2011 |
title_short | Overview of Blood Transfusion System of Iran: 2002–2011 |
title_sort | overview of blood transfusion system of iran: 2002–2011 |
topic | Report Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469026/ https://www.ncbi.nlm.nih.gov/pubmed/23113231 |
work_keys_str_mv | AT cheraghaliam overviewofbloodtransfusionsystemofiran20022011 |